Search results
Author(s):
Andrew E Epstein
Added:
3 years ago
Atrial fibrillation (AF) is the most commonly sustained cardiac arrhythmia observed in clinical practice with a prevalence of over 2,200,000 adults in the US. The prevalence of AF increases with age, from <1% among persons <60 years of age, to approximately 10% among those aged ÔëÑ80 years. AF is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality…
View more
Embolic Protection
Author(s):
Jennifer Franke
,
Horst Sievert
Added:
3 years ago
Article
Author(s):
Andrew E Epstein
Added:
3 years ago
Atrial fibrillation (AF) is the most commonly sustained cardiac arrhythmia observed in clinical practice with a prevalence of over 2,200,000 adults in the US.1 The prevalence of AF increases with age, from <1% among persons <60 years of age, to approximately 10% among those aged ÔëÑ80 years.2 AF is associated with an increased long-term risk of stroke, heart failure, and all-cause mortality…
View more
Author(s):
Jack Collier
,
Arthur J Labovitz
Added:
3 years ago
The approach to the treatment of a variety of cardiovascular disorders has undergone remarkable change over the past two decades. The use of both percutaneous interventions in patients with acute myocardial infarction and automatic implantable cardiodefibrillators in patients with ventricular arrhythmias represent important examples. The cardiology community is currently in the process of another…
View more
Author(s):
Michael M McNally
,
Michael C Stoner
Added:
3 years ago
Treatment for blood clots and their life-threatening sequelae has expanded significantly over the past 50 years. Thrombolytic therapy has gained widespread acceptance and use. Advances in technology have led to experiments with catheter-directed thrombolytic therapy in combination with other physical modality delivery systems, such as ultrasound, to improve the efficacy of thrombolytic therapy…
View more
Wael Almahmeed
Job title: Consultant Cardiologist
Author
Claudio Tondo
Job title: Director
Author
What's Hot at ACC 2020
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
4 years ago
Video
Author(s):
Davide Cao
Added:
2 years ago
Dr Davide Cao (Icahn School of Medicine at Mount Sinai, US) discusses the key results and impact on clinical practice of the pre-specified analysis of the TWILIGHT trial presented at ESC Congress 2021.
TWILIGHT-HBR evaluated the effects of ticagrelor monotherapy versus ticagrelor (Brilinta) plus aspirin on bleeding and ischemic outcomes in a contemporary ARC-defined HBR population undergoing…
View more
Author(s):
Eden C Payabyab
,
Lindsay S Elbaum
,
Navneet Sharma
,
et al
Added:
2 years ago